CORGARD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Corgard, and when can generic versions of Corgard launch?
Corgard is a drug marketed by Uswm and is included in one NDA.
The generic ingredient in CORGARD is nadolol. There are five drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the nadolol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Corgard
A generic version of CORGARD was approved as nadolol by RISING on October 31st, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORGARD?
- What are the global sales for CORGARD?
- What is Average Wholesale Price for CORGARD?
Summary for CORGARD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Clinical Trials: | 2 |
Patent Applications: | 4,544 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CORGARD |
What excipients (inactive ingredients) are in CORGARD? | CORGARD excipients list |
DailyMed Link: | CORGARD at DailyMed |
![CORGARD drug patent expirations Drug patent expirations by year for CORGARD](/p/graph/s/t/CORGARD-patent-expirations.png)
![Drug Prices for CORGARD](/p/graph/drug-price/CORGARD.png)
Recent Clinical Trials for CORGARD
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
AgoneX Biopharmaceuticals, Inc. | Phase 2 |
BioHealthonomics Inc. | Phase 2 |
Sandler Program for Asthma Research | Phase 1/Phase 2 |
Pharmacology for CORGARD
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
US Patents and Regulatory Information for CORGARD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-005 | Oct 28, 1986 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CORGARD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-005 | Oct 28, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Uswm | CORGARD | nadolol | TABLET;ORAL | 018063-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CORGARD
See the table below for patents covering CORGARD around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Argentina | 198639 | PROCEDIMIENTO PARA PREPARAR 2,3- CIS -1, 2, 3, 4-TETRAHIDRO-5-<2-HIDROXI-3-AMINO SUBSTITUIDO PROPOXI>-2,3-NAFTALENODIOLES | ⤷ Sign Up |
Netherlands | 7811648 | ⤷ Sign Up | |
Germany | 2167224 | ⤷ Sign Up | |
United Kingdom | 1358721 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |